Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
J Surg Res. 2019 Jan;233:199-206. doi: 10.1016/j.jss.2018.07.047. Epub 2018 Aug 31.
The effect of cigarette smoking on postoperative morbidity following pancreaticoduodenectomy (PD) for cancer is unclear. We hypothesize that smoking is associated with higher morbidity following PD.
A retrospective review of patients undergoing PD for cancer from 2010 to 2016 at a single institution was performed. Patients who had never smoked were compared to current or past-smokers with at least 1 pack-year history. Univariate and multivariable analyses were performed.
Two hundred fifty-two patients met inclusion criteria. On univariate analysis, there was a significant difference between smokers and never-smokers in age at diagnosis (65.5 versus 68.6 y, P = 0.013) and fistula rate (28.5% versus 16.2%, P = 0.024). Male sex was significantly associated with fistula rate compared with female sex (15.5% versus 7.1%, P = 0.023). Comparing males and females separately, smoking correlated with higher fistula development only in the male cohort (22.5% versus 5.8%, P = 0.016 in men and 7.3% versus 9.1%, P = 1.00 in women). On multivariable analysis, current and past smoking was independently predictive of developing a fistula: odds ratio of 2.038 (P = 0.030). For current and past-smokers, male sex was an independent risk factor for developing a fistula: odds ratio 2.817 (P = 0.022). There were no other significant differences between groups in rates of postoperative complications.
Smoking status is independently predictive of postoperative pancreatic fistula following PD for cancer. Among smokers, male sex is an independent risk factor for fistula. Further studies are needed to determine if smoking cessation before surgery decreases this risk, and if so, the optimal duration of cessation.
吸烟对胰十二指肠切除术(PD)治疗癌症术后发病率的影响尚不清楚。我们假设吸烟与 PD 术后发病率升高有关。
对单中心 2010 年至 2016 年间接受 PD 治疗癌症的患者进行回顾性研究。将从未吸烟的患者与至少有 1 包年吸烟史的现吸烟者或既往吸烟者进行比较。进行单因素和多因素分析。
252 例患者符合纳入标准。在单因素分析中,吸烟者和从不吸烟者在诊断时的年龄(65.5 岁与 68.6 岁,P=0.013)和瘘管发生率(28.5%与 16.2%,P=0.024)方面存在显著差异。与女性相比,男性的瘘管发生率显著更高(15.5%与 7.1%,P=0.023)。单独比较男性和女性,仅在男性队列中吸烟与更高的瘘管发生率相关(22.5%与 5.8%,P=0.016;男性 7.3%与女性 9.1%,P=1.00)。多因素分析显示,目前和既往吸烟是发生瘘管的独立预测因素:比值比为 2.038(P=0.030)。对于目前和既往吸烟者,男性是发生瘘管的独立危险因素:比值比为 2.817(P=0.022)。两组间其他术后并发症发生率无显著差异。
吸烟状态是 PD 治疗癌症术后发生胰瘘的独立预测因素。在吸烟者中,男性是瘘管的独立危险因素。需要进一步研究以确定术前戒烟是否能降低这种风险,如果可以,那么最佳的戒烟时间是多久。